5851 - 5900 of 8471 Results
Title
Year
- Recruitment of patients with de novo Parkinson disease: successful strategies in a randomized exercise clinical trial2018OPENTitle: Recruitment of patients with de novo Parkinson disease: successful strategies in a randomized exercise clinical trialJournal Name: TrialsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13063-018-2958-zBest OA location URL: https://trialsjournal.biomedcentral.com/track/pdf/10.1186/s13063-018-2958-zCitation Count: 11
- RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8A2018OPENTitle: RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8AJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2018.00417Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2018.00417/pdfCitation Count: 43
-
RESTRICTEDTitle: Dietary Patterns, Physical Activity, Sleep, and Risk for Dementia and Cognitive DeclineJournal Name: Current Nutrition ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 4Start Page: 335End Page: 345Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13668-018-0247-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13668-018-0247-9.pdfCitation Count: 57
- Evidence for increased completed suicide in first-degree relatives of LRRK2 G2019S mutation Parkinson’s disease2018OPENTitle: Evidence for increased completed suicide in first-degree relatives of LRRK2 G2019S mutation Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 90Issue #: 7Start Page: 843End Page: 844Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2018-319364Best OA location URL: https://europepmc.org/articles/pmc6506381?pdf=renderCitation Count: 0
-
OPENTitle: Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 1Start Page: 96End Page: 104Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25376Citation Count: 36
-
OPENTitle: Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progressionJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-35130-yBest OA location URL: https://www.nature.com/articles/s41598-018-35130-y.pdfCitation Count: 46
- A pathway for Parkinson’s Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain2018OPENTitle: A pathway for Parkinson’s Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brainJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.40202Best OA location URL: https://doi.org/10.7554/elife.40202Citation Count: 227
- Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates2018OPENTitle: Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman PrimatesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 10Issue #: 3Start Page: 1544End Page: 1554Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00526Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6810685Citation Count: 98
- Targeting the pedunculopontine nucleus in Parkinson's disease: Time to go back to the drawing board2018RESTRICTEDTitle: Targeting the pedunculopontine nucleus in Parkinson's disease: Time to go back to the drawing boardJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 12Start Page: 1871End Page: 1875Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27540Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/147041/2/mds27540_am.pdfCitation Count: 19
-
OPENTitle: Portrait of blood-derived extracellular vesicles in patients with Parkinson’s diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 124Issue #:Start Page: 163End Page: 175Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.11.002Best OA location URL: https://www.repository.cam.ac.uk/bitstream/1810/287349/1/YNBDI_2018_257_Original_V0-2-4-72.pdfCitation Count: 43
-
OPENTitle: RAB7A phosphorylation by TBK1 promotes mitophagy via the PINK-PARKIN pathwayJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 4Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.aav0443Best OA location URL: https://advances.sciencemag.org/content/advances/4/11/eaav0443.full.pdfCitation Count: 162
- Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure2018OPENTitle: Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter MicrostructureJournal Name: Frontiers in EndocrinologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fendo.2018.00608Best OA location URL: https://www.frontiersin.org/articles/10.3389/fendo.2018.00608/pdfCitation Count: 17
- Dissociation between urate and blood pressure in mice and in people with early Parkinson's disease2018OPENTitle: Dissociation between urate and blood pressure in mice and in people with early Parkinson's diseaseJournal Name: EBioMedicinePublisher: Elsevier BVVol: 37Issue #:Start Page: 259End Page: 268Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2018.10.039Best OA location URL: http://www.thelancet.com/article/S2352396418304572/pdfCitation Count: 9
-
OPENTitle: Phosphorylation of Parkin at serine 65 is essential for its activationin vivoJournal Name: Open BiologyPublisher: The Royal SocietyVol: 8Issue #: 11Start Page: 180108End Page: 180108Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1098/rsob.180108Best OA location URL: https://royalsocietypublishing.org/doi/pdf/10.1098/rsob.180108Citation Count: 109
- The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN212018OPENTitle: The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN21Journal Name: Cell ReportsPublisher: Elsevier BVVol: 25Issue #: 9Start Page: 2484End Page: 2496.e9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2018.11.002Best OA location URL: http://www.cell.com/article/S2211124718317315/pdfCitation Count: 36
- Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice2018OPENTitle: Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in miceJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 465Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aah4066Best OA location URL: https://stm.sciencemag.org/content/scitransmed/10/465/eaah4066.full.pdfCitation Count: 707
-
OPENTitle: Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson’s DiseaseJournal Name: MetabolitesPublisher: MDPI AGVol: 8Issue #: 4Start Page: 71End Page: 71Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/metabo8040071Best OA location URL: https://www.mdpi.com/2218-1989/8/4/71/pdfCitation Count: 51
-
OPENTitle: The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohortJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 5Issue #: 12Start Page: 1460End Page: 1477Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.644Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.644Citation Count: 472
-
OPENTitle: The vermiform appendix impacts the risk of developing Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 465Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aar5280Best OA location URL: https://hal.science/hal-04247698v1/file/nihms-1002856.pdfCitation Count: 245
- δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer’s disease2018OPENTitle: δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer’s diseaseJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 26Issue #: 2Start Page: 586End Page: 603Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-018-0286-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6684859Citation Count: 71
- A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein2018OPENTitle: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-SynucleinJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 1Start Page: 31End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181471Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181471?id=journal-of-parkinsons-disease%2Fjpd181471Citation Count: 50
-
OPENTitle: Parkin targets NOD2 to regulate astrocyte endoplasmic reticulum stress and inflammationJournal Name: GliaPublisher: WileyVol: 66Issue #: 11Start Page: 2427End Page: 2437Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/glia.23482Best OA location URL: https://europepmc.org/articles/pmc6275110?pdf=renderCitation Count: 50
- The Luxembourg Parkinson’s Study: A Comprehensive Approach for Stratification and Early Diagnosis2018OPENTitle: The Luxembourg Parkinson’s Study: A Comprehensive Approach for Stratification and Early DiagnosisJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00326Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00326/pdfCitation Count: 82
- Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 42018OPENTitle: Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4Journal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-018-1337-8Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-018-1337-8Citation Count: 42
- The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease2018OPENTitle: The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-34490-9Best OA location URL: https://www.nature.com/articles/s41598-018-34490-9.pdfCitation Count: 139
-
OPENTitle: A comprehensive screening of copy number variability in dementia with Lewy bodiesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 75Issue #:Start Page: 223.e1End Page: 223.e10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.10.019Best OA location URL: http://rihuc.huc.min-saude.pt/bitstream/10400.4/2247/1/comprehensive.pdfCitation Count: 16
-
RESTRICTEDTitle: PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathologyJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 12Start Page: 1961End Page: 1965Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27523Citation Count: 43
- The transition between turning and sitting in patients with Parkinson's disease: A wearable device detects an unexpected sequence of events2018OPENTitle: The transition between turning and sitting in patients with Parkinson's disease: A wearable device detects an unexpected sequence of eventsJournal Name: Gait & PosturePublisher: Elsevier BVVol: 67Issue #:Start Page: 224End Page: 229Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2018.10.018Best OA location URL: https://europepmc.org/articles/pmc6287952?pdf=renderCitation Count: 32
- Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers2018OPENTitle: Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 15Issue #: 2Start Page: 232End Page: 244Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2018.08.012Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2018.08.012Citation Count: 275
- Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies2018OPENTitle: Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathiesJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 28Issue #: 4Start Page: 548End Page: 560Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddy365Best OA location URL: https://academic.oup.com/hmg/article-pdf/28/4/548/27636558/ddy365.pdfCitation Count: 64
- Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stress2018OPENTitle: Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stressJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 144Issue #:Start Page: 19End Page: 28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2018.10.013Best OA location URL: https://europepmc.org/articles/pmc6286225?pdf=renderCitation Count: 52
-
OPENTitle: Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-33921-xBest OA location URL: https://www.nature.com/articles/s41598-018-33921-x.pdfCitation Count: 100
- Phenotypic Reprogramming of Striatal Neurons into Dopaminergic Neuron-like Cells in the Adult Mouse Brain2018OPENTitle: Phenotypic Reprogramming of Striatal Neurons into Dopaminergic Neuron-like Cells in the Adult Mouse BrainJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 11Issue #: 5Start Page: 1156End Page: 1170Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2018.09.004Best OA location URL: http://www.cell.com/article/S2213671118303898/pdfCitation Count: 43
- Validation of a performance‐based assessment of cognitive functional ability in Parkinson's disease2018OPENTitle: Validation of a performance‐based assessment of cognitive functional ability in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1760End Page: 1768Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27487Best OA location URL: https://europepmc.org/articles/pmc6261681?pdf=renderCitation Count: 18
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference2018OPENTitle: Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage InferenceJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-018-05892-0Best OA location URL: https://www.nature.com/articles/s41467-018-05892-0.pdfCitation Count: 418
-
OPENTitle: Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s DiseaseJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 18Issue #: 2Start Page: 212End Page: 224Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-018-0981-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-018-0981-y.pdfCitation Count: 18
- Progressive Decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging Data2018OPENTitle: Progressive Decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging DataJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00318Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00318/pdfCitation Count: 70
- Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 22018OPENTitle: Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2Journal Name: Neurochemical ResearchPublisher: Springer Science and Business Media LLCVol: 44Issue #: 6Start Page: 1446End Page: 1459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11064-018-2650-4Best OA location URL: https://europepmc.org/articles/pmc6450775?pdf=renderCitation Count: 9
- 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's disease2018RESTRICTEDTitle: 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1734End Page: 1739Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27451Citation Count: 12
- Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease2018OPENTitle: Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-018-0282-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-018-0282-4Citation Count: 198
- Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial2018OPENTitle: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 51End Page: 56Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005Best OA location URL: http://manuscript.elsevier.com/S1353802018304310/pdf/S1353802018304310.pdfCitation Count: 16
-
OPENTitle: Abstracts from the 50th European Society of Human Genetics Conference: PostersJournal Name: European Journal of Human GeneticsPublisher: Springer Science and Business Media LLCVol: 26Issue #: S1Start Page: 113End Page: 819Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41431-018-0247-7Best OA location URL: https://www.nature.com/articles/s41431-018-0247-7.pdfCitation Count: 3
-
OPENTitle: Importance of low diagnostic Accuracy for early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1551End Page: 1554Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27485Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6544441Citation Count: 104
-
RESTRICTEDTitle: Meta-analysis of amantadine efficacy for improving preclinical research reliabilityJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1555End Page: 1557Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27486Citation Count: 7
- Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current options2018RESTRICTEDTitle: Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current optionsJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 352Issue #:Start Page: 142End Page: 150Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2017.12.014Citation Count: 20
-
RESTRICTEDTitle: Sleep disorders and Parkinson disease; lessons from geneticsJournal Name: Sleep Medicine ReviewsPublisher: Elsevier BVVol: 41Issue #:Start Page: 101End Page: 112Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.smrv.2018.01.006Best OA location URL: http://escholarship.mcgill.ca/downloads/tb09j975fCitation Count: 33
-
RESTRICTEDTitle: The Linked Clinical Trials initiative (LCT) for Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 49Issue #: 3Start Page: 307End Page: 315Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.14175Citation Count: 19
- Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches2018RESTRICTEDTitle: Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New ApproachesJournal Name: Bioconjugate ChemistryPublisher: American Chemical Society (ACS)Vol: 29Issue #: 12Start Page: 3937End Page: 3966Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.8b00548Best OA location URL: https://europepmc.org/articles/pmc7234797?pdf=renderCitation Count: 24
-
OPENTitle: Modulation of intracellular calcium signaling by microRNA-34a-5pJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-018-1050-7Best OA location URL: https://www.nature.com/articles/s41419-018-1050-7.pdfCitation Count: 28
- Regional vesicular acetylcholine transporter distribution in human brain: A [18F]fluoroethoxybenzovesamicol positron emission tomography study2018OPENTitle: Regional vesicular acetylcholine transporter distribution in human brain: A [18F]fluoroethoxybenzovesamicol positron emission tomography studyJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 526Issue #: 17Start Page: 2884End Page: 2897Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.24541Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/146604/1/cne24541.pdfCitation Count: 58